Developmental disorders include rare paediatric diseases resulting from a genetic, developmental abnormality during foetal or postnatal growth. Developmental medicine is a broad area of focus at the University of Oxford and within the Harrington Discovery Institute. Atul Chopra, MD, PhD at Harrington Discovery Institute specializes in rare, genetic metabolic and hormonal diseases. The OHC will work in partnership with the new Institute of Developmental and Regenerative Medicine (IDRM), due to open in 2022. The mission of the Institute will be to develop new drugs for disorders that have a developmental origin, including neurodevelopmental disorders. Oxford’s Cardiovascular Medicine Division has world-leading groups researching rare inherited heart disease, focusing on screening, disease models, imaging and novel therapeutics.